Recruiting OBSERVATIONAL NCT06642831
Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study (PHOEBE)
Polycystic Ovarian Syndrome (PCOS) in Human Adolescent and Young Adult Females - Biomarker Evaluation Study (PHOEBE)
Sponsor: Roche Diagnostics International AG
Conditions
Polycystic Ovarian Syndrome (PCOS)
Updated 1 time since 2024 Last updated: Oct 14, 2024 Started: Jan 31, 2023 Primary completion: Dec 31, 2026 Completion: Mar 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Polycystic Ovarian Syndrome (PCOS) and is currently actively recruiting participants. Roche Diagnostics International AG leads this study, which shows 1 recorded version since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Roche Diagnostics International AG
- University Hospital Erlangen
Data source: University Hospital Erlangen
For direct contact, visit the study record on ClinicalTrials.gov .